SER Key Financial Ratios - Serina Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	6.65	—	-82.03%	-113.05%
2026-03-31	4.18	—	-77.90%	-120.64%
2025-12-31	1.71	—	-275.96%	51843.24%
2025-09-30	1.31	—	-149.73%	-1056.02%
2025-06-30	2.24	—	-140.82%	-698.72%
2025-03-31	2.45	—	-13.95%	-55.20%
2024-12-31	2.4	—	-165.69%	-1738.07%
2024-09-30	0.4	—	-98.86%	53.36%
2024-06-30	0.71	—	-65.45%	42.83%
2024-03-31	0.64	—	-105.05%	264.66%
2023-12-31	5.39	—	58.75%	-16.32%
2023-09-30	0.36	—	12.41%	-5.50%
2023-06-30	0.06	—	-21.76%	12.05%
2023-03-31	0.08	—	-48.66%	16.88%
2022-12-31	0.24	—	-322.80%	27.69%
2022-09-30	0.13	—	-493.87%	65.66%
2022-06-30	0.19	—	-365.92%	71.40%
2022-03-31	0.18	—	-342.16%	80.48%
2021-12-31	0.25	—	-275.05%	73.32%
2021-09-30	0.22	—	-369.30%	90.21%
2021-06-30	0.3	—	-375.88%	115.74%
2021-03-31	0.55	—	-309.05%	161.10%
2020-12-31	0.43	—	-276.82%	212.37%
2020-09-30	0.4	—	-264.81%	304.85%
2020-06-30	0.45	—	-248.22%	483.14%
2020-03-31	0.38	—	-239.75%	1651.96%
2019-12-31	1.23	—	-163.32%	-547.97%
2019-09-30	1.61	—	-154.33%	-291.06%
2019-06-30	2.54	—	-112.69%	-171.32%
2019-03-31	—	—	-84.41%	-111.58%
2018-12-31	3.22	—	-70.30%	-100.74%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	1.71	—	-275.96%	51843.24%
2024-12-31	2.4	—	-165.69%	-1738.07%
2023-12-31	5.39	—	58.75%	-16.32%
2022-12-31	0.24	—	-322.80%	60.78%
2021-12-31	0.25	—	-275.05%	73.32%
2020-12-31	0.43	—	-276.82%	212.37%
2019-12-31	1.23	—	-163.32%	-547.97%
2018-12-31	—	—	-70.30%	-100.74%
2017-12-31	—	—	-68.32%	-90.38%